BOSTON, March 2, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced today that Co-Founder and CEO Jason Kelly is scheduled to participate in Cowen's 43^rd Annual Health Care Conference, including:

• Fireside chat on Monday, March 6, 2023, at 9:10 a.m. ET
• SynBio & AI Driven Drug Discovery panel on Monday, March 6, 2023, at 4:40 p.m. ET

Further details, webcast links, and a replay of the fireside chat and panel, if available, will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events/.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

This email address is being protected from spambots. You need JavaScript enabled to view it.

MEDIA CONTACT:

This email address is being protected from spambots. You need JavaScript enabled to view it.